Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

BACKGROUND: Immunosuppressive cell-based therapy is a recent strategy for controlling Graft-versus-Host Disease (GvHD). Such cells ought to maintain their suppressive function in inflammatory conditions and in the presence of immunosuppressive agents currently used in allogeneic hematopoietic cell t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Janikashvili, Nona, Gérard, Claire, Thébault, Marine, Brazdova, Andrea, Boibessot, Clovis, Cladière, Claudie, Ciudad, Marion, Greigert, Hélène, Ouandji, Séthi, Ghesquière, Thibault, Samson, Maxime, Audia, Sylvain, Saas, Philippe, Bonnotte, Bernard
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899641/
https://ncbi.nlm.nih.gov/pubmed/33659098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1880046
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires